Article

Clarification attempt of the mechanism of late recurrence by micro- and macro-analyses in estrogen receptor-positive breast cancer

2023-10-27

Abstract excerpt

<title>Abstract</title> <p>Purpose The mechanism of late recurrence (LR) of estrogen receptor (ER)-positive breast cancer remains unclear. As prediction models for LR of ER-positive breast cancer, 42-gene classifier (42GC), which analyzes “micro-factors (gene expression patterns)” and the Clinical Treatment Score post-5 years (CTS5), which analyzes “macro-factors (clinicopathological factors)”, were developed; h...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: f016840a-9a89-5477-b5ea-ffdcd8c3df11
DOI: 10.21203/rs.3.rs-3389190/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Clarification attempt of the mechanism of late recurrence by micro- and macro-analyses in estrogen receptor-positive breast cancerDOI 10.21203/rs.3.rs-3389190/v1Read

Impact of Different Modules of 21-Gene Assay in Early Breast Cancer PatientsSemantic proximity Read

Comparison of time-varying recurrence patterns in breast cancer patients with different molecular subtypes treated from 2008 to 2012 and from 2013 to 2016: a single-center retrospective studySemantic proximity Read

Correlation Analysis of 21-Gene Recurrence Score with Gene Pathway Expression and Clinicopathological Features in Hormone Receptor-Positive Early-Stage Breast CancerSemantic proximity Read

Multi-state modeling associates proliferation genes with early estrogen receptor-positive breast cancer recurrence and survivalSemantic proximity Read

Evaluation of 95-Gene Classifier of Formalin-Fixed Paraffin-Embedded Tissues in ER-Positive, HER2-Negative, and Node-Negative Breast CancerSemantic proximity Read

A nomogram to predict the high-risk RS in HR+/HER2-breast cancer patients older than 50 years of ageSemantic proximity Read

Validation of a Clinical-Genomic Model for Patients With Early-Stage Breast Cancer Enrolled in a Taiwanese Multicenter StudySemantic proximity Read

Validation of the predictive ability for recurrence and the clinical utility of the 95-gene classifier (95GC) through an integrated analysis of five studies.Semantic proximity Read

RecurrenceOnline: an online analysis tool to determine breast cancer recurrence and hormone receptor status using microarray data.Semantic proximity Read

Novel Gene Signatures Predictive of Patient Recurrence-free Survival in HR+HER2- Breast CancerSemantic proximity Read

Gene Expression Profiles for Recurrence of Lymph Node-positive Primary Breast Cancer in Women Over 40 Years of AgeSemantic proximity Read

Comparative Evaluation of a 28-Gene versus 70-Gene Panel for Recurrence Risk Prediction in Early-Stage HR-Positive/HER2-Negative Breast Cancer in Chinese WomenSemantic proximity Read